{"zip": "541-8564", "sector": "Healthcare", "fullTimeEmployees": 3560, "longBusinessSummary": "Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER Capsule for improvement of the symptoms in patients with pheochromocytoma; and BRAFTOVI capsules, and MEKTOVI and VELEXBRU tablets for malignant tumors. It also provides GLACTIV and FORXIGA tablets for type 2 diabetes; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; PARSABIV, an intravenous injection for dialysis patients; ONOACT injections for tachyarrhythmia; STAYBLA tablets for overactive bladder; OPALMON tablets to treat peripheral circulatory disorder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; CORALAN for treatment of chronic heart failure; and RECALBON tablets for osteoporosis. In addition, the company is developing products for colorectal, esophageal, gastric or esophago-gastric junction, small and non-small cell lung, ovarian, pancreatic, prostate, biliary tract, hematologic, and head and neck cancers; hepatocellular, urothelial, and virus positive/negative solid carcinoma; glioblastoma; multiple myeloma; malignant pleural mesothelioma; solid tumors; central nervous system, primary testicular, and lymphoplasmacytic; acute myeloid leukemia; melanoma; primary macroglobulinemia; chronic heart failure; Parkinson's disease; structural damage of the joints in rheumatoid arthritis; polymyositis/dermatomyositis; osteoarthritis; enthesopathy; pemphigus; celebral infarction; acromegaly; thrombosis; and autoimmune disease. The company has research and option agreement with Numab Therapeutics AG. Ono Pharmaceutical Co., Ltd. was founded in 1717 and is headquartered in Osaka, Japan.", "city": "Osaka", "phone": "81 6 6263 5670", "country": "Japan", "companyOfficers": [], "website": "http://www.ono.co.jp", "maxAge": 1, "address1": "8-2, Kyutaromachi 1-chome", "fax": "81 6 6263 2976", "industry": "Drug Manufacturers\u2014General", "address2": "Chuo-ku", "previousClose": 2743.5, "regularMarketOpen": 2693, "twoHundredDayAverage": 3126.2837, "trailingAnnualDividendYield": 0.016402405, "payoutRatio": 0.3018, "volume24Hr": null, "regularMarketDayHigh": 2702, "navPrice": null, "averageDailyVolume10Day": 1116750, "totalAssets": null, "regularMarketPreviousClose": 2743.5, "fiftyDayAverage": 2926.1943, "trailingAnnualDividendRate": 45, "open": 2693, "averageVolume10days": 1116750, "expireDate": null, "yield": null, "algorithm": null, "dividendRate": 45, "exDividendDate": 1617062400, "beta": 0.400664, "circulatingSupply": null, "startDate": null, "regularMarketDayLow": 2525.5, "priceHint": 2, "currency": "JPY", "trailingPE": 17.028135, "regularMarketVolume": 3125800, "lastMarket": null, "maxSupply": null, "openInterest": null, "marketCap": 1265765842944, "volumeAllCurrencies": null, "strikePrice": null, "averageVolume": 1138762, "priceToSalesTrailing12Months": 4.190528, "dayLow": 2525.5, "ask": 0, "ytdReturn": null, "askSize": 0, "volume": 3125800, "fiftyTwoWeekHigh": 3422, "forwardPE": 2131.0923, "fromCurrency": null, "fiveYearAvgDividendYield": 1.62, "fiftyTwoWeekLow": 2467.5, "bid": 0, "tradeable": false, "dividendYield": 0.0164, "bidSize": 0, "dayHigh": 2702, "exchange": "JPX", "shortName": "ONO PHARMACEUTICAL CO", "longName": "Ono Pharmaceutical Co., Ltd.", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "isEsgPopulated": true, "gmtOffSetMilliseconds": "32400000", "underlyingSymbol": null, "quoteType": "EQUITY", "symbol": "4528.T", "underlyingExchangeSymbol": null, "headSymbol": null, "messageBoardId": "finmb_876950", "uuid": "94294152-92a6-332c-9351-0ff8b5ad5418", "market": "jp_market", "annualHoldingsTurnover": null, "enterpriseToRevenue": 4.275, "beta3Year": null, "profitMargins": 0.24619, "enterpriseToEbitda": 11.798, "52WeekChange": null, "morningStarRiskRating": null, "forwardEps": 1.19, "revenueQuarterlyGrowth": null, "sharesOutstanding": 499119008, "fundInceptionDate": null, "annualReportExpenseRatio": null, "bookValue": 1247.356, "sharesShort": null, "sharesPercentSharesOut": null, "fundFamily": null, "lastFiscalYearEnd": 1585612800, "heldPercentInstitutions": 0.34334, "netIncomeToCommon": 74364002304, "trailingEps": 148.93, "lastDividendValue": null, "SandP52WeekChange": null, "priceToBook": 2.0331004, "heldPercentInsiders": 0.17920999, "nextFiscalYearEnd": 1648684800, "mostRecentQuarter": 1609372800, "shortRatio": null, "sharesShortPreviousMonthDate": null, "floatShares": 464901081, "enterpriseValue": 1291383341056, "threeYearAverageReturn": null, "lastSplitDate": 1459209600, "lastSplitFactor": "5:1", "legalType": null, "morningStarOverallRating": null, "earningsQuarterlyGrowth": 0.401, "dateShortInterest": null, "pegRatio": 25841.6, "lastCapGain": null, "shortPercentOfFloat": null, "sharesShortPriorMonth": null, "category": null, "fiveYearAverageReturn": null, "regularMarketPrice": 2693, "logo_url": "https://logo.clearbit.com/ono.co.jp"}